Galenus Rx Celebrates Larry Lesko’s Recognition for Top Downloaded Article in Leading Clinical Journal
Galenus Rx is thrilled to announce that Larry Lesko, the Chair of our newly formed Scientific Advisory Board and a longtime advisor, has been recognized for co-authoring one of the Top Downloaded Articles in the prestigious journal “Clinical and Translational Science” by the American Society for Clinical Pharmacology and Therapeutics. The article, “A case study […]
My Doctor Says I Need 5-FU: What Should I Do?
The NIH estimates that roughly 275,000 cancer patients in the U.S. receive 5-FU, or chemotherapy drug 5-fluorouracil, annually. Up to 3% of those patients experience a toxic reaction. If your oncologist recommends 5-FU as a cancer treatment, you’ll likely have a lot of questions. “Does this treatment make the most sense for my cancer?” “What […]
Hospitalogy Features Galenus Rx as Innovative Startup
Hospitalogy’s May 2024 newsletter highlights Galenus Rx in its Innovative Startup section. Galenus Rx addresses the significant issue of unoptimized medication regimens, which cost billions in preventable adverse drug events and excess morbidity. Their platform, APPRAISE, offers advanced medication safety assessments, analyzing drug interactions down to the DNA level to provide actionable insights for safer […]
The Impact of Community Pharmacy Reimbursement
How did we get here, and what does it mean for the future of pharmacy practice?
healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program
Partnership Aims to Reduce Adverse Drug Events by Combining Pharmacogenomic Testing and Precision Medication Consultation to Provide Personalized Medication Support Plans for healthŌme Policyholders.
Hannover Re US Partners with GalenusRx for Personalized, Precision Medication Safety Services
Supporting Improved Quality and Outcomes for Healthcare Division Clients
